Weekly Briefing No. 44 | A Fintech Opportunity in the EpiPen Fiasco?

Weekly Briefing No. 44 | A Fintech Opportunity in the EpiPen Fiasco?

As the summer winds fade, we look back at Mylan Labs’ EpiPen fiasco and ponder a possible fintech opportunity. We also take note of Apple’s nasty battle with Aussie banks, the resilience of some fallen unicorns, an ETF issuer’s reinvention as a fintech company, a blockchain non-problem and the end of a tech-bank celebrity marriage. Finally, we highlight Snagajob, a gig economy standout.

Read More